115 related articles for article (PubMed ID: 9780114)
1. Cyclosporine-induced optic neuropathy, ophthalmoplegia, and nystagmus in a patient with Crohn disease.
Porges Y; Blumen S; Fireman Z; Sternberg A; Zamir D
Am J Ophthalmol; 1998 Oct; 126(4):607-9. PubMed ID: 9780114
[TBL] [Abstract][Full Text] [Related]
2. Bilateral optic neuropathy after bone marrow transplantation and cyclosporin A therapy.
Walter SH; Bertz H; Gerling J
Graefes Arch Clin Exp Ophthalmol; 2000 Jun; 238(6):472-6. PubMed ID: 10943669
[TBL] [Abstract][Full Text] [Related]
3. Early isolated optic neuropathy caused by cyclosporine.
Mimouni K; Lusky M; Kramer M; Gdalevich M; Weinberger D; Mimouni M
Int Ophthalmol; 2019 Apr; 39(4):853-860. PubMed ID: 29532216
[TBL] [Abstract][Full Text] [Related]
4. A case of cyclosporine-induced optic neuropathy with a normal therapeutic level of cyclosporine.
Akagi T; Manabe S; Ishigooka H
Jpn J Ophthalmol; 2010 Jan; 54(1):102-4. PubMed ID: 20151288
[No Abstract] [Full Text] [Related]
5. Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.
Jasse L; Vukusic S; Durand-Dubief F; Vartin C; Piras C; Bernard M; Pélisson D; Confavreux C; Vighetto A; Tilikete C
Mult Scler; 2013 Oct; 19(12):1618-26. PubMed ID: 23462348
[TBL] [Abstract][Full Text] [Related]
6. [Bilateral optic atrophy in a drug addict].
Milet A; Blaise P; Andris C; Rakic JM
J Fr Ophtalmol; 2007 Nov; 30(9):e29. PubMed ID: 18046269
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine A does not prevent second-eye involvement in Leber's hereditary optic neuropathy.
Leruez S; Verny C; Bonneau D; Procaccio V; Lenaers G; Amati-Bonneau P; Reynier P; Scherer C; Prundean A; Orssaud C; Zanlonghi X; Rougier MB; Tilikete C; Miléa D
Orphanet J Rare Dis; 2018 Feb; 13(1):33. PubMed ID: 29454364
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
9. Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.
Openshaw H; Slatkin NE; Smith E
Bone Marrow Transplant; 1997 Mar; 19(5):503-5. PubMed ID: 9052919
[TBL] [Abstract][Full Text] [Related]
10. Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy.
Barton JJ; Cox TA
J Neurol Neurosurg Psychiatry; 1993 Mar; 56(3):262-7. PubMed ID: 8459242
[TBL] [Abstract][Full Text] [Related]
11. Neuro-ophthalmology.
Knox DL
Arch Ophthalmol; 1970 Jan; 83(1):103-25. PubMed ID: 4190335
[No Abstract] [Full Text] [Related]
12. [Bilateral optic neuropathy following amiodarone therapy].
Krieg P; Schipper I
Klin Monbl Augenheilkd; 1992 Feb; 200(2):128-32. PubMed ID: 1578863
[TBL] [Abstract][Full Text] [Related]
13. Bilateral optic neuropathy associated with amiodarone therapy.
Nazarian SM; Jay WM
J Clin Neuroophthalmol; 1988 Mar; 8(1):25-8. PubMed ID: 2972746
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity pneumonitis probably caused by cyclosporine. A case report.
Roelofs PM; Klinkhamer PJ; Gooszen HC
Respir Med; 1998 Dec; 92(12):1368-70. PubMed ID: 10197232
[No Abstract] [Full Text] [Related]
15. Toxic damage to the optic nerve caused by iodochlorhydroxyquinoline (enterovioform).
van Balen AT
Ophthalmologica; 1971; 163(1):8-9. PubMed ID: 4257124
[No Abstract] [Full Text] [Related]
16. Severe bone pain as an adverse effect of cyclosporin therapy for Crohn's disease.
Isaacs KL
Inflamm Bowel Dis; 1998 May; 4(2):95-7. PubMed ID: 9589296
[TBL] [Abstract][Full Text] [Related]
17. [Sarcoidosis of the optic nerve].
Asensio Sánchez VM; Corral Azor A; Bartolomé Aragón A; De Paz García M
Arch Soc Esp Oftalmol; 2003 Mar; 78(3):165-8. PubMed ID: 12677494
[TBL] [Abstract][Full Text] [Related]
18. FRONTAL LOBE TUMORS AND THEIR OCULAR MANIFESTATIONS.
CROLL M
Am J Ophthalmol; 1965 Feb; 59():206-11. PubMed ID: 14268792
[No Abstract] [Full Text] [Related]
19. Cyclosporine-Induced neurotoxicity during treatment of Crohn's disease: lack of correlation with previously reported risk factors.
Rosencrantz R; Moon A; Raynes H; Spivak W
Am J Gastroenterol; 2001 Sep; 96(9):2778-82. PubMed ID: 11569712
[TBL] [Abstract][Full Text] [Related]
20. Methyl bromide optic atrophy.
Chavez CT; Hepler RS; Straatsma BR
Am J Ophthalmol; 1985 Jun; 99(6):715-9. PubMed ID: 2990215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
